Condition: Colectomy · Open Surgery · Pain · Sponsor: University of Ioannina
The role of perioperative IV administration of nimodipine, an L-type calcium channel antagonist which is capable of crossing the blood-brain barrier, on peri-operative opioid and anesthetics requirements, pain intensity, opioid-related side effects and early postoperative bowel mobility in patients undergoing surgical treatment for bowel cancer with open radical colectomy remains scarcely explored. A prospective double-blind, randomized controlled trial investigating the effect of perioperative IV administration of nimodipine in patients undergoing open colectomy for cancer treatment is therefore conducted.
This description comes directly from the study's public registry record.
Maria-Theodora Filou, MD · 00306948127570 · marilizafilou@gmail.com
Ourania Patroni, MD · 00302613601673 · patronirania@gmail.com
Always discuss trial participation with your own doctor first.
| St. Andrews General Hospital of Patras, GREECE | Pátrai, Achaea, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07048522